- Home
- CLPR vs PRE Comparison
CLPR vs PRE Comparison
Compare CLPR & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- PRE
- Stock Information
- Founded
- CLPR 2015
- PRE 2014
- Country
- CLPR United States
- PRE Hong Kong
- Employees
- CLPR N/A
- PRE N/A
- Industry
- CLPR Real Estate Investment Trusts
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- CLPR Real Estate
- PRE Industrials
- Exchange
- CLPR Nasdaq
- PRE Nasdaq
- Market Cap
- CLPR 63.5M
- PRE 60.2M
- IPO Year
- CLPR 2017
- PRE N/A
- Fundamental
- Price
- CLPR $5.11
- PRE $4.45
- Analyst Decision
- CLPR Sell
- PRE Buy
- Analyst Count
- CLPR 2
- PRE 1
- Target Price
- CLPR N/A
- PRE $9.00
- AVG Volume (30 Days)
- CLPR 108.7K
- PRE 6.2K
- Earning Date
- CLPR 10-31-2024
- PRE 11-26-2024
- Dividend Yield
- CLPR 7.36%
- PRE N/A
- EPS Growth
- CLPR N/A
- PRE N/A
- EPS
- CLPR N/A
- PRE N/A
- Revenue
- CLPR $145,595,000.00
- PRE $22,662,330.00
- Revenue This Year
- CLPR N/A
- PRE $64.44
- Revenue Next Year
- CLPR N/A
- PRE $154.24
- P/E Ratio
- CLPR N/A
- PRE N/A
- Revenue Growth
- CLPR 6.78
- PRE N/A
- 52 Week Low
- CLPR $3.38
- PRE $2.85
- 52 Week High
- CLPR $7.12
- PRE $7.84
- Technical
- Relative Strength Index (RSI)
- CLPR 34.82
- PRE 49.60
- Support Level
- CLPR $5.01
- PRE $4.40
- Resistance Level
- CLPR $6.40
- PRE $4.85
- Average True Range (ATR)
- CLPR 0.24
- PRE 0.25
- MACD
- CLPR -0.12
- PRE 0.01
- Stochastic Oscillator
- CLPR 7.19
- PRE 64.58
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.